A Study to Assess the Effects of a Medication in Patients with Angina
The purpose of this study is to evaluate the effects (possible risks and the effectiveness) of the investigational drug (drug that is not approved by the United States Food and Drug Administration (FDA)) SAR407899. This study will look at SAR407899 within the dose range between 2.5mg and 10mg, by mouth, twice daily compared to placebo (substance that contains no active medication).
- Complete tests including a physical exam, blood sample, PET scan and ECG
- Take study medication
- 6 visits over a 36 day period
- Persistent stable chest pain
Can be done from home
KeywordsAngina, Chest pain, Stable angina
Principal InvestigatorCarl Pepine, MD
Begin a new search for other research studies
Studies listed on this site have been approved by a UF Institutional Review Board (IRB), which works to ensure the welfare and rights of research participants as required by federal regulations. Study listings are provided by the UF Clinical and Translational Science Institute in collaboration with UF research teams and the UF IRBs.